ArticleFrontiers in bioengineering and biotechnology2026
The interrelationship between calcium-phosphorus homeostasis and bone remodelling. Impact of dietary changes on bone in patients with primary hyperparathyroidism and chronic kidney disease.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Calcium-phosphorus homeostasis is closely linked to bone remodelling, and disturbances in either system contribute to bone loss in conditions such as chronic kidney disease and hyperparathyroidism. Existing physiological models, such as the Peterson and Riggs formulation, incorporate systemic Ca/P regulation but often rely on simplified representations of bone turnover. Consequently, current frameworks generally lack the detailed coupling between systemic mineral balance and the cellular mechanisms of bone remodelling required to evaluate how endocrine imbalance, renal dysfunction, or dietary changes jointly affect bone metabolism. Methods: In this work, we develop an integrated mathematical framework that overhauls the bone compartment of the Peterson and Riggs model by coupling it with a mechanistic cell-population model, while also introducing refined descriptions of systemic mineral fluxes. The model incorporates dynamic PTH regulation, mineral exchange between plasma, bone marrow, and bone matrix, and a revised mineralisation algorithm that links systemic mineral availability to local bone properties. Results: After calibration against clinical data for vitamin D deficiency, chronic kidney disease, and primary hyperparathyroidism, we use the model to explore how changes in dietary calcium, phosphate, and vitamin D intake influence Ca/P homeostasis and bone density under healthy and pathological conditions. Discussion: This integrated approach captures multiscale interactions between systemic mineral regulation and cellular bone remodelling, enabling quantitative analysis of disease mechanisms and the impact of dietary interventions on skeletal health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.